The role of non-resolving inflammation in atherosclerosis

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880

Cytokine-mediated regulation of CXCR4 expression in human neutrophils

Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713

The M1 and M2 paradigm of macrophage activation: Time for reassessment

Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial

(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812

Alternative Activation of Macrophages: An Immunologic Functional Perspective

Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745

Macrophages in the Pathogenesis of Atherosclerosis

Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669

Mechanisms of plaque formation and rupture

Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391

The immune system in atherosclerosis

Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389

Downregulation of G3BP2 reduces atherosclerotic lesions in ApoE mice

Li, T., Safitri, M., Zhang, K., Wang, Y., Huang, L., Zhu, Y. S., Daniel, R. A., Wu, L. J., Qiu, J., & Wang, G. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.003 · Cited by 29

Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis

Kraft, J. D., Blomgran, R., Bergström, I., Soták, M., Clark, M., Rani, A., Rajan, M. R., Dalli, J., Nyström, S., Quiding‐Järbrink, M., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101219rr · Cited by 29

eNOS-Nitric Oxide System Contributes to a Novel Antiatherogenic Effect of Leonurine via Inflammation Inhibition and Plaque Stabilization

Ning, K., Wang, M.-J., Ge, L., Zhang, Y., Li, M.-Y., Yang, B., Chen, Y., Huang, Y., Li, Z., Huang, Y., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264887 · Cited by 29

Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy

Ke, X., Huang, Y., Li, L., Xin, F., Xu, L., Zhang, Y., Zeng, Z., Lin, F., & Song, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s250524 · Cited by 28

Thioredoxin-1 attenuates atherosclerosis development through inhibiting NLRP3 inflammasome

Wang, Y., Ji, N., Gong, X., Ni, S., Xu, L., & Zhang, H. (2020) · Endocrine · doi:10.1007/s12020-020-02389-z · Cited by 28

Omega-3 and cardiovascular prevention – Is this still a choice?

Ruscica, M., Sirtori, C. R., Carugo, S., Calder, P. C., & Corsini, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106342 · Cited by 29

Phytochemical-mediated efferocytosis and autophagy in inflammation control

Vafadar, A., Tajbakhsh, A., Hosseinpour-Soleimani, F., Savardshtaki, A., & Hashempur, M. H. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02254-2 · Cited by 27

Specialized pro-resolving mediators in diabetes: novel therapeutic strategies

Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30

The Beneficial Effect of Coarse Cereals on Chronic Diseases through Regulating Gut Microbiota

Ren, G., Fan, X. M., Teng, C., Li, Y., Everaert, N., & Blecker, C. S. (2021) · Foods · doi:10.3390/foods10112891 · Cited by 28

Serum Cytokines Predict the Severity of Coronary Artery Disease Without Acute Myocardial Infarction

Liu, S., Wang, C., Guo, J., Yang, Y., Huang, M., Li, L., Wang, Y., Qin, Y., & Zhang, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.896810 · Cited by 27

Pomegranate Peel Extract Decreases Plaque Necrosis and Advanced Atherosclerosis Progression in Apoe-/- Mice

Manickam, V., Dhawan, U. K., Singh, D., Gupta, M., & Subramanian, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888300 · Cited by 28

Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids

Manzini, S., Busnelli, M., Parolini, C., Minoli, L., Ossoli, A., Brambilla, E., Simonelli, S., Lekka, E., Persidis, A., Scanziani, E., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.022 · Cited by 27

A Theranostic Cathepsin Activity-Based Probe for Noninvasive Intervention in Cardiovascular Diseases

Weiss‐Sadan, T., Ben‐Nun, Y., Maimoun, D., Merquiol, E., Elrahman, I. A., Gotsman, I., & Blum, G. (2019) · Theranostics · doi:10.7150/thno.34402 · Cited by 27

The double-edged role and therapeutic potential of TREM2 in atherosclerosis

Zhu, B., Liu, Y., & Peng, D. (2024) · Biomarker Research · doi:10.1186/s40364-024-00675-w · Cited by 28

Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases

Andrews, D. C., & Godson, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158940 · Cited by 27

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis

Salazar, J. J., Pírela, D., Nava, M., Castro, A. V., Angarita, L., Parra, H., Durán‐Agüero, S., Rojas-Gómez, D. M., Galbán, N., Áñez, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063133 · Cited by 26

Oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis

Xie, H., Qin, Z., Ling, Z., Ge, X., Zhang, H., Guo, S., Liu, L., Zheng, K., Jiang, H., & Xu, R. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00232-5 · Cited by 28

Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation

Liu, Y., Luehmann, H. P., Detering, L., Pressly, E. D., McGrath, A. J., Sultan, D. H., Nguyen, A., Grathwohl, S. A., Shokeen, M., Zayed, M. A., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b02750 · Cited by 25

Palmitic Acid–Induced Long Noncoding RNA PARAIL Regulates Inflammation via Interaction With RNA-Binding Protein ELAVL1 in Monocytes and Macrophages

Tanwar, V. S., Reddy, M. A., Das, S., Samara, V. A., Abdollahi, M., Dey, S., Malek, V., Ganguly, R., Stapleton, K., Lanting, L. L., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318536 · Cited by 25

Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p/NF-κB Signal Pathway

Shi, Z., Zheng, Z., Lin, X., & Ma, H. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001061 · Cited by 24

Antibodies in action: the role of humoral immunity in the fight against atherosclerosis

Taylor, J. A., Hutchinson, M. A., Gearhart, P. J., & Maul, R. W. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00316-6 · Cited by 24

A Zombie Macrophage‐Based “Trojan horse” Enhances the Effect of Efferocytosis Through Immune Regulation for Atherosclerosis Treatment

Yao, Y., Chen, H., Barkat, A., Liao, F., Xiao, Y., Zhao, Z., Liu, L., Wang, W., Ma, J., Fu, C., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202315034 · Cited by 23

Shear Stress and ROS Dual-Responsive RBC-Hitchhiking Nanoparticles for Atherosclerosis Therapy

Shen, M., Jiang, H., Zhao, Y., Wu, L., Yang, H., Yao, Y., Meng, H., Yang, Q., Liu, L., & Li, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c07371 · Cited by 23

Resolvin D2/GPR 18 axis ameliorates pressure overload-induced heart failure by inhibiting pro-inflammatory macrophage polarization

Zheng, Z., Zhao, M., Xu, Y., Zhang, J., Peng, S., Liu, J., Pan, W. D., Yin, Z., Wei, C., Qin, J., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100679 · Cited by 22

Precision cardiovascular medicine: shifting the innovation paradigm

Aikawa, M., Sonawane, A. R., Chelvanambi, S., Asano, T., Halu, A., Matamalas, J. T., Singh, S. A., Uchida, S., Aïkawa, E., Arenas, À., et al. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1474469 · Cited by 24

Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment

Hu, Z.-P., Fang, X., Sheng, B., Guo, Y., & Yu, Y. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106659 · Cited by 22

Human Macrophage Long Intergenic Noncoding RNA, SIMALR , Suppresses Inflammatory Macrophage Apoptosis via NTN1 (Netrin-1)

Cynn, E., Li, D. Y., O'Reilly, M. E., Wang, Y., Bashore, A. C., Jha, A., Foulkes, A. S., Zhang, H., Winter, H., Mäegdefessel, L., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318353 · Cited by 21

Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18

Lipscomb, M., Walis, S., Marinello, M., Mena, H. A., MacNamara, K. C., Spite, M. R., & Fredman, G. (2024) · The FASEB Journal · doi:10.1096/fj.202302336rr · Cited by 21

Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance

Ouyang, X., & Liu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1435021 · Cited by 19

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

Li, C., Wang, Z., Yang, Y., Jiang, Q., Jiang, Y., Xiao, J., Shen, L., Wu, W., & Li, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00400-5 · Cited by 22

Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases

Sun, H., Lu, Q.-B., Zhu, X., Ni, Z.-R., Su, J., Fu, X., Guo, C., Zheng, G.-L., Nie, X.-W., & Bian, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000928 · Cited by 19

Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease

Prouse, T., Majumder, S., & Majumder, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312736 · Cited by 20

Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?

Yvan‐Charvet, L., & Ivanov, S. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.2.231 · Cited by 19

Interleukin‐36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome

Tian, Y., Ling, X., Chen, D., Zhang, X., & Qiu, C.-M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29813 · Cited by 19

ANGPTL4 Expression Is Increased in Epicardial Adipose Tissue of Patients with Coronary Artery Disease

Katanasaka, Y., Saito, A., Sunagawa, Y., Sari, N., Funamoto, M., Shimizu, S., Shimizu, K., Akimoto, T., Ueki, C., Kitano, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092449 · Cited by 19

Global research trends in atherosclerosis: A bibliometric and visualized study

Tian, W., Zhang, T., Wang, X., Zhang, J., Ju, J., & Xu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.956482 · Cited by 18

Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities

Yang, Y., Deng, N.-H., Tian, K.-J., Liu, L.-S., Wang, Z., Wei, D., Liu, H., & Jiang, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.909178 · Cited by 18

The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy

Xu, H., Fu, J., Tu, Q., Shuai, Q. Y., Chen, Y., Wu, F., & Cao, Z. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00974-0 · Cited by 17

EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment

Zhang, X., Ren, Z., & Jiang, Z. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04544-8 · Cited by 16

Emerging roles of macrophages in heart failure and associated treatment approaches

Xie, L., Chen, J., Wang, Y., Jin, C., Xie, Y., Ma, H., & Xiang, M. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231168755 · Cited by 16

Efferocytosis in Health and Disease

Li, C., Yang, Y., Zhou, F., Jiang, Q., Jiang, Y., Huang, X., Zhang, Y., Ye, Z., Xu, G. X., Kao, G., et al. (2025) · MedComm · doi:10.1002/mco2.70546 · Cited by 15

Tear Film Amphiphilic and Anti-Inflammatory Lipids in Bovine Pink Eye

Wood, P. L., Donohue, M. N., Cebak, J. E., Beckmann, T. G., Treece, M., Johnson, J. W., & Miller, L. M. J. (2018) · Metabolites · doi:10.3390/metabo8040081 · Cited by 15

Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies

Kamato, D., Ilyas, I., Xu, S., & Little, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112964 · Cited by 14

Trichostatin D as a Novel KLF2 Activator Attenuates TNFα-Induced Endothelial Inflammation

Lei, L., Chen, M., Wang, C., Jiang, X., Li, Y., Wang, W., Li, S., Zhao, L., Sheng, R., Han, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113477 · Cited by 14

Roles of Lipoxygenases in Cardiovascular Diseases

Liu, T., & Ai, D. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10605-2 · Cited by 16

Macrophage Long Non-Coding RNAs in Pathogenesis of Cardiovascular Disease

Wysoczynski, M., Kim, J. I., Moore, J. B., & Uchida, S. (2020) · Non-Coding RNA · doi:10.3390/ncrna6030028 · Cited by 14

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

Zhang, S., Wang, J., Chen, S., Zhang, Y., He, R., Wang, X., Ding, F., Hu, W., Dai, Y., Lu, L., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03931-x · Cited by 13

Bioactive Lipids in Inflammation After Central Nervous System Injury

López‐Vales, R., & David, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_12 · Cited by 13

PP2A alleviates oxidized LDL-induced endothelial dysfunction by regulating LOX-1/ROS/MAPK axis

Xu, K., Liu, X., Yin, D., Ren, G., & Zhao, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117270 · Cited by 13

Drimys winteri and isodrimeninol decreased foam cell formation in THP-1 derived macrophages

Burgos, V., Paz, C., Saavedra, K., Saavedra, N., Foglio, M. A., González‐Chavarría, I., & Salazar, L. A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111842 · Cited by 13

Exercise for slowing the progression of atherosclerotic process: effects on inflammatory markers

Testa, C., Lorenzo, A. D., Parlato, A., D’AMBROSIO, G., Merolla, A., Pacileo, M., Iannuzzo, G., Gentile, M., Nugara, C., Sarullo, F. M., et al. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04266-x · Cited by 13

Crosstalk Between Cholesterol, ABC Transporters, and PIP2 in Inflammation and Atherosclerosis

Gulshan, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_13 · Cited by 12

PTX3 alleviates hard metal-induced acute lung injury through potentiating efferocytosis

Yan, W., Ma, D., Liu, Y., Sun, W., Cheng, D., Li, G., Zhou, S., Wang, Y., Wang, H., & Ni, C. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113139 · Cited by 12

Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis

Xiang, Z., Yang, J. M., Yang, J., Zhang, J., Fan, Z., Yang, C., Di, L., Ma, C., Wu, J., & Huang, Y. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02606-7 · Cited by 12

Meta-analysis of the association between interleukin-17 and ischemic cardiovascular disease

Yu, M., Yan, T., Liu, J., Zhang, C., Yan, J., Xu, L., Zhang, N., & Zhang, X. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03897-w · Cited by 11

Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers

Yang, Y., Du, L., Zhao, H., Zhao, Y., Liao, S., Zhang, Z., Zhang, S., Bai, Y., & Zheng, X. (2025) · Medicinal Research Reviews · doi:10.1002/med.22102 · Cited by 11

The Biochemical Markers Associated with the Occurrence of Coronary Spasm

Li, L., Jin, Y., Xia, S.-D., & Feng, C. (2019) · BioMed Research International · doi:10.1155/2019/4834202 · Cited by 11

Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1

Seneviratne, A. N., Han, Y., Wong, E., Walter, E. R. H., Jiang, L., Cave, L., Long, N. J., Carling, D., Mason, J. C., Haskard, D. O., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315528 · Cited by 11

Deep learning reveals 3D atherosclerotic plaque distribution and composition

Jurtz, V. I., Skovbjerg, G., Salinas, C. G., Roostalu, U., Pedersen, L., Hecksher‐Sørensen, J., Rolin, B., Nyberg, M., van de Bunt, M., & Ingvorsen, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-78632-4 · Cited by 11

Areca catechu-(Betel-nut)-induced whole transcriptome changes in a human monocyte cell line that may have relevance to diabetes and obesity; a pilot study

Cardosa, S. R., Ogunkolade, B.-W., Lowe, R., Savage, E., Mein, C. A., Boucher, B. J., & Hitman, G. A. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00827-1 · Cited by 11

Metabolic Regulators of Vascular Inflammation

Fairman, G., Robichaud, S., & Ouimet, M. I. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312582 · Cited by 11

“A Time to Tear Down and a Time to Mend”: The Role of Eicosanoids in Atherosclerosis

Sherratt, S. C. R., Mason, R. P., Libby, P., & Bhatt, D. L. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319570 · Cited by 12

Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis

Kotlyarov, S. N. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673303369240312092913 · Cited by 10

Application trends of hydrogen-generating nanomaterials for the treatment of ROS-related diseases

Li, X., Wang, X., Chen, G., & Tian, B. (2024) · Biomaterials Science · doi:10.1039/d4bm01450b · Cited by 10

Aseptic Loosening in Total Hip Arthroplasty: Pathophysiology, Biomarkers, and Preventive Treatment Strategies

Ricciardi, G., Siracusano, L., Micale, E., Addorisio, V., Ballato, M., Donadio, D., Tralongo, P., Giuffrè, G., Leonetti, D., Martini, M., et al. (2025) · Applied Sciences · doi:10.3390/app15169156 · Cited by 10

Cardiovascular disease risk calculators to reflect the subclinical atherosclerosis of coronary artery in rheumatoid arthritis: a pilot study

Kim, S. H., Lee, S., Kim, H., & Min, H. K. (2021) · BMC Rheumatology · doi:10.1186/s41927-021-00213-3 · Cited by 10

Synbiotic Compositions of Bacillus megaterium and Polyunsaturated Fatty Acid Salt Enable Self-Sufficient Production of Specialized Pro-Resolving Mediators

Speckmann, B., Kleinbölting, J., Börner, F., Jordan, P. M., Werz, O., Pelzer, S., Dieck, H. T., Wagner, T., & Schön, C. (2022) · Nutrients · doi:10.3390/nu14112265 · Cited by 10

Inflammation in atherosclerosis: a Big Idea that has underperformed so far

Williams, K. J. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000973 · Cited by 9

Macrophage polarization by potential nutraceutical compounds: A strategic approach to counteract inflammation in atherosclerosis

Sottero, B., Testa, G., Gamba, P., Staurenghi, E., Giannelli, S., & Leonarduzzi, G. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.02.010 · Cited by 9

Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases

de Gaetano, M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101699 · Cited by 9

Chemokine Ligands and Receptors Regulate Macrophage Polarization in Atherosclerosis: A Comprehensive Database Mining Study

Yu, W., Fu, L., Lei, G., Luo, F., Yu, P., Shen, W., Wu, Q., & Yang, P. (2024) · CJC Open · doi:10.1016/j.cjco.2024.11.018 · Cited by 8

Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study

Wang, Y., Zhu, X.-T., & Hu, Z.-P. (2025) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2025.106990 · Cited by 8

Oxylipins in Atherosclerosis: Their Role in Inflammation, Diagnosis, and Therapeutic Perspectives

Chistyakov, D. V., Chistyakov, V. V., & Sergeeva, M. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110577 · Cited by 8

Interleukin-6 Signaling in Atherosclerosis: From Molecular Mechanisms To Clinical Outcomes

Papastamos, C., Antonopoulos, A. S., Simantiris, S., Κούμαλλος, Ν., Sagris, Μ., Theofilis, P., Oikonomou, E. K., Siasos, G., Tsioufis, K. P., & Tousoulis, D. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230718141235 · Cited by 8

Hemodynamics combined with inflammatory indicators exploring relationships between ischemic stroke and symptomatic middle cerebral artery atherosclerotic stenosis

Wu, X., Liu, Y., Huang, L., Guo, X., Cai, W., Luo, B., & Wang, S. (2023) · European journal of medical research · doi:10.1186/s40001-023-01344-8 · Cited by 9

Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials

Xu, H., Mao, L., Liu, H., Lin, Z., Zhang, Y., & Yang, J. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.09.017 · Cited by 8

Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation

Undi, R. B., Filiberti, A., Ali, N., & Huycke, M. M. (2022) · Cancers · doi:10.3390/cancers14112811 · Cited by 9

The Role of Macrophages in Atherosclerosis: Participants and Therapists

Liu, X., Pang, S., Jiang, Y., Wang, L., & Liu, Y. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07513-5 · Cited by 7

In Vivo Comparative Study of Radioiodinated Folate Receptor Targeting Albumin Probes for Atherosclerosis Plaque Imaging

Wen, X., Zeng, X., Liu, J., Zeng, X., Zhang, Y., Cheng, X., Huang, J., Li, Y., Zhuang, R., Zhang, X., et al. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00486 · Cited by 7

Association of systemic inflammatory response index and plaque characteristics with the severity and recurrence of cerebral ischemic events

Wei, X., Cheng, J., Zhang, L., Xu, R., & Zhang, W. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107558 · Cited by 7

Metabolomic Profiling Reveals Distinct and Mutual Effects of Diet and Inflammation in Shaping Systemic Metabolism in Ldlr−/− Mice

Lauterbach, M., Latz, E., & Christ, A. (2020) · Metabolites · doi:10.3390/metabo10090336 · Cited by 7

Low-grade endotoxaemia and platelets: a deadly aggregation

Liberale, L., & Gorog, D. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz955 · Cited by 7

An Updated Review on the Anti‐Inflammatory Potential of Phyllanthus Genus

Bhattacharyya, J., Saikia, L., Kalita, V., & Dutta, P. P. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402483 · Cited by 6

Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques

Lipscomb, M., del Rio, I. S., Eid, M., Rahtes, A., Martino, G., Sadhu, S., Khan, S., MacNamara, K. C., & Fredman, G. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107527 · Cited by 6

Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation

Amedei, A., Lamminpää, I., & Parolini, C. (2025) · Biomedicines · doi:10.3390/biomedicines13102428 · Cited by 6

Immunology of atherosclerosis as an inflammatory disease: rethinking the dynamic immunoinflammatory activity beneath stability

Miceli, G., Ciaccio, A. M., Cuffaro, M., Profita, M., & Tuttolomondo, A. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575449 · Cited by 6

Assessing Efferocytosis in Atherosclerotic Lesions In Situ.

Yurdagul, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_34 · Cited by 6

Association between tissue human neutrophil peptide 1–3 levels and cardiovascular phenotype: a prospective, longitudinal cohort study

Fanne, R. A., Arbel, Y., Chorin, E., Maraga, E., Groisman, G. M., Higazi, A. A., & Banai, S. (2022) · Journal of International Medical Research · doi:10.1177/03000605221127099 · Cited by 6

Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review

Sandoval, C., Nahuelqueo, K., Mella, L., Recabarren, B., Souza‐Mello, V., & Farías, J. G. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1288804 · Cited by 6

Prostaglandin E2 Boosts the Hyaluronan-Mediated Increase in Inflammatory Response to Lipopolysaccharide by Enhancing Lyve1 Expression

Hog, P., Kuntschar, S., Rappl, P., Huard, A., Weigert, A., Brüne, B., & Schmid, T. (2023) · Biology · doi:10.3390/biology12111441 · Cited by 6

Novel strategies to promote resolution of inflammation to treat lower extremity artery disease

Zhang, Q., Li, F., Ritchie, R. H., Woodman, O. L., Zhou, X., & Qin, C. X. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102263 · Cited by 6

The role and mechanism of the annexin A1 peptide Ac2‐26 in rats with cardiopulmonary bypass lung injury

Xu, J., Yu, C., Luo, J., Guo, Y., Cheng, C., & Zhang, H. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13561 · Cited by 6

Self-Assembled CuCo2S4 Nanoparticles for Efficient Chemo-Photothermal Therapy of Arterial Inflammation

Lu, R., Wang, W., Dong, B., Xu, C. Y., Li, B., Sun, Y., Liu, J., & Hong, B. (2022) · Molecules · doi:10.3390/molecules27238134 · Cited by 6

Should We Use Genetic Scores in the Determination of Treatment Strategies to Control Dyslipidemias?

Lechner, K., Kessler, T., & Schunkert, H. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01408-9 · Cited by 6

Who Done It?

Zhang, H., & Reilly, M. P. (2018) · Circulation Research · doi:10.1161/circresaha.118.314006 · Cited by 6

Correlation between α-ketoglutarate and the oxidative stress response in patients with coronary heart disease and prognostic analysis of interventional therapy for coronary heart disease

Deng, H., & Zhang, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1544537 · Cited by 5

Efferocytosis in Homeostasis

Maueröder, C., Gillis, C. M., & Ravichandran, K. S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_2 · Cited by 5

The TREM Receptor Family in Cardiovascular Diseases: Functions, Mechanisms and Therapeutic Perspectives

Liu, W., Liu, Y., Guo, X., Cao, C., Weng, S., & Peng, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116167 · Cited by 5

Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trials

Bao, R.-H., Zhao, N., Jiang, X., Cong, Z.-H., Liu, J., Kang, L., Chen, Y.-H., Sun, J., Xing, W.-Y., Liu, J.-X., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103277 · Cited by 6

The Influence of Smoking and Systemic Inflammation on Carotid Artery Disease: A Cross-Sectional Analysis of Stenosis, Plaque Surface Characteristics

Altıparmak, T., Çağlayan, H. Z. B., Kesen, S., Öncü, F., Kılıç, A. C. K., Erdoğan, T., Yaymaci, S., & Nazlıel, B. (2025) · Angiology · doi:10.1177/00033197251356577 · Cited by 5

Fine-tuning inflammation-resolution programs

Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341

Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities

Subramanian, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_361

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411

Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?

Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22